Latest Episodes
-
Looking ahead at fintech’s comeback
Listen nowThe past year has been a big one for fintech startups. The high interest rate environment we’ve been under is slowly easing, along with the uncertainties stemming from having to wait for the outcome of the election in the US. The huge amounts of capital that have been parked on the sidelines are now looking to be deployed, and momentum is returning to the fintech space.
-
We are in another iPhone Cambrian explosion for the chips industry
Listen nowFor every dollar that is invested in semiconductors, around $3 of economic activity is thought to be generated downstream – and in this case, downstream means absolutely anything technology-related. Just about piece of tech equipment you can buy today will rely in some way on a semi-conductor.
-
Torq hopes to replicate Brazil’s fintech success across LatAm
Listen nowLatin America has always been fertile ground for fintech innovation and growth. Combining a young, tech-savvy population and a relative under-penetration of financial services you may see in other developed markets, there is plenty of opportunity for startups to feast on.
-
Best Nights VC wants people to meet in real life again
Listen nowNightlife has changed in recent years. It’s not just the macro-effects of the pandemic – with higher costs of living and young people having less disposable income – but their preferences are also evolving.
-
How to get first-of-a-kind cleantech projects off the ground
Listen nowWe’ve got a bit of a different episode again this week – Fernando sits down with GCV’s editor-in-chief Maija Palmer, who asks him some questions about a recent report he wrote for GCV’s Global Energy Council on the topic of getting first-of-a-kind cleantech technologies and projects of the ground.
-
M&A and liquidity making a slower comeback in healthcare, but CVCs are stepping up to the plate
Listen nowAt the beginning of the year, I spoke to Bill Taranto, president of the MSD Global Health Innovation Fund about what he expected over the course of the year in the healthcare space. He had predicted that M&As would make a moderate comeback and more liquidity would be coming into the market from private equity firms, and that we would see a wave of consolidations taking shape as smaller “point solutions” get integrated into larger platforms.
-
While others are cautious in a slower Brazilian market, L4 wants to be greedy
Listen nowThe past year has not been the most active for the Brazilian CVC market. High interest rates, lack of sufficient liquidity, and decreased dealflow, among other things, have all slowed it down relative to past years. But that is not true across the board. Some funds, like, L4 Venture Builder – the single-LP fund backed by Brazil’s main stock exchange, B3 – have been investing a lot since it officially launched early in 2023.
-
How Olympus Innovation Ventures is looking into the human body
Listen nowTo fix things in the human body, you have to see them. This is what Olympus does. The legendary Japanese camera-maker, which in recent years divested its camera business and went full-tilt into medical devices, retains its core strength of optics and doubling down in its application to medicine.
-
Opening a new CVC office in the US is not easy – here’s how Lotte Ventures is doing it
Listen nowWith Lotte Group’s expansion into biotech, it wanted its CVC, Lotte Ventures, to set up a new office in the world’s largest biotech innovation ecosystem, the US, with a new – 3-person team in the Bay Area. But going into a new market is never a walk in the park.
-
The US healthcare system has a huge resource shortage. Here’s how small and medium-sized investors can help plug the gap.
Listen nowThe group of smaller and medium-sized investors has been growing, and their value has never been clearer to founders and co-investors. They tend not to seek M&As, neutralising a concern that some startups have about having corporates on their cap table, while still bringing the advantage of corporate connections. They often place an even heavier emphasis on the health of the investment syndicate, as they may be in a worse position than larger funds if things fall through, and they often opt, for example, for observer seats over board seats. All in all, they are team players who can still open very important doors.